Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

NCT00670046 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped The study was terminated per the PI decision.

Conditions

Prostate Cancer

Interventions

DRUG: valproic acid
OTHER: standard of care follow-up

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]